These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34182001)

  • 21. Combination of Human Mesenchymal Stem Cells and Repetitive Transcranial Magnetic Stimulation Enhances Neurological Recovery of 6-Hydroxydopamine Model of Parkinsonian's Disease.
    Lee JY; Kim HS; Kim SH; Kim HS; Cho BP
    Tissue Eng Regen Med; 2020 Feb; 17(1):67-80. PubMed ID: 31970698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insights into the Effects of Mesenchymal Stem Cell-Derived Secretome in Parkinson's Disease.
    d'Angelo M; Cimini A; Castelli V
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32718092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trabecular meshwork mesenchymal stem cell transplantation improve motor symptoms of parkinsonian rat model.
    Mostafavi H; Ghassemifard L; Rostami A; Alipour M; Nadri S
    Biologicals; 2019 Sep; 61():61-67. PubMed ID: 31262640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic effects of intranigral transplantation of mesenchymal stem cells in rat models of Parkinson's disease.
    Chen D; Fu W; Zhuang W; Lv C; Li F; Wang X
    J Neurosci Res; 2017 Mar; 95(3):907-917. PubMed ID: 27617772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenchymal Stem Cell Secretome Improves Tendon Cell Viability In Vitro and Tendon-Bone Healing In Vivo When a Tissue Engineering Strategy Is Used in a Rat Model of Chronic Massive Rotator Cuff Tear.
    Sevivas N; Teixeira FG; Portugal R; Direito-Santos B; Espregueira-Mendes J; Oliveira FJ; Silva RF; Sousa N; Sow WT; Nguyen LTH; Ng KW; Salgado AJ
    Am J Sports Med; 2018 Feb; 46(2):449-459. PubMed ID: 29053925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteomic Profiling of the Human Fetal Multipotent Mesenchymal Stromal Cells Secretome.
    Lobov AA; Yudintceva NM; Mittenberg AG; Shabelnikov SV; Mikhailova NA; Malashicheva AB; Khotin MG
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33198321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transplanted Wharton's jelly mesenchymal stem cells improve memory and brain hippocampal electrophysiology in rat model of Parkinson's disease.
    Jalali MS; Sarkaki A; Farbood Y; Azandeh SS; Mansouri E; Ghasemi Dehcheshmeh M; Saki G
    J Chem Neuroanat; 2020 Dec; 110():101865. PubMed ID: 32991967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell secretome based approaches in Parkinson's disease regenerative medicine.
    Marques CR; Marote A; Mendes-Pinheiro B; Teixeira FG; Salgado AJ
    Expert Opin Biol Ther; 2018 Dec; 18(12):1235-1245. PubMed ID: 30422014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Neuroprotective Role of MiR-124-3p in a 6-Hydroxydopamine-Induced Cell Model of Parkinson's Disease via the Regulation of ANAX5.
    Dong RF; Zhang B; Tai LW; Liu HM; Shi FK; Liu NN
    J Cell Biochem; 2018 Jan; 119(1):269-277. PubMed ID: 28543594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual Effects of Human Placenta-Derived Neural Cells on Neuroprotection and the Inhibition of Neuroinflammation in a Rodent Model of Parkinson's Disease.
    Kim HW; Lee HS; Kang JM; Bae SH; Kim C; Lee SH; Schwarz J; Kim GJ; Kim JS; Cha DH; Kim J; Chang SW; Lee TH; Moon J
    Cell Transplant; 2018 May; 27(5):814-830. PubMed ID: 29871515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined transplantation of neural stem cells and bone marrow mesenchymal stem cells promotes neuronal cell survival to alleviate brain damage after cardiac arrest
    Li F; Zhang J; Chen A; Liao R; Duan Y; Xu Y; Tao L
    Aging (Albany NY); 2021 Jan; 13(1):262-278. PubMed ID: 33436530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extracellular vesicles from bone marrow mesenchymal stem/stromal cells transport tumor regulatory microRNA, proteins, and metabolites.
    Vallabhaneni KC; Penfornis P; Dhule S; Guillonneau F; Adams KV; Mo YY; Xu R; Liu Y; Watabe K; Vemuri MC; Pochampally R
    Oncotarget; 2015 Mar; 6(7):4953-67. PubMed ID: 25669974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of passage number on the impact of the secretome of adipose tissue stem cells on neural survival, neurodifferentiation and axonal growth.
    Serra SC; Costa JC; Assunção-Silva RC; Teixeira FG; Silva NA; Anjo SI; Manadas B; Gimble JM; Behie LA; Salgado AJ
    Biochimie; 2018 Dec; 155():119-128. PubMed ID: 30342112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroprotective effects of lentivirus-mediated cystathionine-beta-synthase overexpression against 6-OHDA-induced parkinson's disease rats.
    Yin WL; Yin WG; Huang BS; Wu LX
    Neurosci Lett; 2017 Sep; 657():45-52. PubMed ID: 28764908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic efficacy of AAV8-mediated intrastriatal delivery of human cerebral dopamine neurotrophic factor in 6-OHDA-induced parkinsonian rat models with different disease progression.
    Wang L; Wang Z; Zhu R; Bi J; Feng X; Liu W; Wu J; Zhang H; Wu H; Kong W; Yu B; Yu X
    PLoS One; 2017; 12(6):e0179476. PubMed ID: 28622392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Native characterization and QC profiling of human amniotic mesenchymal stromal cell vesicular fractions for secretome-based therapy.
    Marassi V; La Rocca G; Placci A; Muntiu A; Vincenzoni F; Vitali A; Desiderio C; Maraldi T; Beretti F; Russo E; Miceli V; Conaldi PG; Papait A; Romele P; Cargnoni A; Silini AR; Alviano F; Parolini O; Giordani S; Zattoni A; Reschiglian P; Roda B
    Talanta; 2024 Aug; 276():126216. PubMed ID: 38761653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Aging on the 6-OHDA-Induced Rat Model of Parkinson's Disease.
    Barata-Antunes S; Teixeira FG; Mendes-Pinheiro B; Domingues AV; Vilaça-Faria H; Marote A; Silva D; Sousa RA; Salgado AJ
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32422916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotective Potential of Superparamagnetic Iron Oxide Nanoparticles Along with Exposure to Electromagnetic Field in 6-OHDA Rat Model of Parkinson's Disease.
    Umarao P; Bose S; Bhattacharyya S; Kumar A; Jain S
    J Nanosci Nanotechnol; 2016 Jan; 16(1):261-9. PubMed ID: 27398453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The beneficial effect of vanillin on 6-hydroxydopamine rat model of Parkinson's disease.
    Abuthawabeh R; Abuirmeileh AN; Alzoubi KH
    Restor Neurol Neurosci; 2020; 38(5):369-373. PubMed ID: 32986633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotective effect of human mesenchymal stem cells in a compartmentalized neuronal membrane system.
    Piscioneri A; Morelli S; Mele M; Canonaco M; Bilotta E; Pantano P; Drioli E; De Bartolo L
    Acta Biomater; 2015 Sep; 24():297-308. PubMed ID: 26087109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.